Star Combo Pharma Limited announced earnings results for the half year ended December 31, 2020. For the half year, the company announced sales was AUD 14.671 million compared to AUD 21.117 million a year ago. Net income was AUD 530,397 compared to net loss of AUD 1.232 million a year ago. Basic earnings per share from continuing operations was AUD 0.004 compared to basic loss per share from continuing operations of AUD 0.01 a year ago.